L&C Bio announced that it introduced the world’s first ECM-based skin booster, Re2O (리투오), at the MSAAH Congress 2026 held in Myanmar, drawing significant attention from local medical professionals.
The congress, themed 'Innovative Global Trends in Aesthetic Medicine, Anti-aging and Hair Restoration,' was organized by Myanmar but attracted aesthetic and regenerative medicine experts from across Southeast Asia to share the latest global trends.
The Re2O launch session was the most attended. Professor Joo-hee Lee, Vice Chairman of L&C Bio and a special professor at Yonsei University College of Medicine, presented on 'The Ultimate Skin Restoration with Human ECM-based Skin Booster Platform: Re2O.' In her lecture, she explained skin aging and damage not merely as volume loss but as an ECM (Extracellular Matrix) microenvironment collapse, emphasizing the importance of ECM-based regenerative aesthetics. She also introduced Re2O as a leader in the longevity platform based on human-derived ECM scaffolds, along with various basic research and clinical data.
Dr. Dong-woo Shin of Nabi Plastic Surgery Clinic followed with a lecture on 'Micronized Acellular Dermal Matrix: Expanding Clinical Applications in Surgical and Aesthetic Fields.' He shared clinical experiences with micronized acellular dermal matrix and practical application cases and protocols in aesthetic surgery, capturing attendees’ interest.
Dr. Su Phyo Aung, Director of a clinic in Myanmar and moderator of the session, commented, 'I already knew that Re2O is the most well-known ECM skin booster in Korea, and I believe it is the product with the strongest basic and clinical evidence presented so far.' He added, 'In Myanmar, we plan to utilize Re2O not only for skin regeneration but also for hair regeneration, accumulating real-world clinical data.' The session saw continuous inquiries about Re2O, confirming high interest in ECM-based regenerative platforms.
Hwan-chul Lee, Chairman of L&C Bio, stated, 'The global aesthetic medicine market is rapidly shifting from simple filling to regenerative approaches that naturally improve skin structure and function.' He added, 'Re2O, as the world’s first ECM-based skin booster platform, is accelerating global market expansion based on differentiated technology and clinical evidence. Following the launch of Re2O Fine in Singapore last week, clinical adoption is rapidly increasing in Asian markets, and we plan to lead global K-regenerative aesthetics through Re2O in about 20 countries worldwide by the end of the year.'
Source: Read the original report | Published: May 26, 2026